Skip to main content
Research  >  About SRI  >  Scientist Profiles
Scientist profiles G-L

Sunnybrook Research Institute

David Juurlink, MD, FRCPC, PhD

Scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room G1 57
Toronto, ON
M4N 3M5

Phone: 416-480-4055, ext. 3039
Fax: 416.480.6048

Administrative Assistant: Karen Arbour
Phone:
416-480-6100 ext. 3780
Fax: 416-480-6048
Email: Karen.Arbour@ices.on.ca

Education:

  • B.Phm., 1990, Pharmacy, Dalhousie University, Canada
  • MD, 1994, Medicine, Dalhousie University, Canada
  • FRCPC, 1998, Internal Medicine, University of Toronto, Canada
  • FRCPC, 2000, Clinical Pharmacology, University of Toronto, Canada
  • Fellowship, 2002, Medical Toxicology, University of Toronto, Canada
  • PhD, 2003, Clinical Epidemiology, University of Toronto, Canada

Appointments and Affiliations:

  • Scientist, evaluative clinical sciences - Schulich Heart Research Program, Sunnybrook Research Institute
  • Scientist, Institute for Clinical Evaluative Sciences
  • Associate professor, departments of medicine and pediatrics, University of Toronto
  • Staff physician, divisions of general internal medicine and clinical pharmacology, Sunnybrook Health Sciences Centre
  • Medical toxicologist, Ontario Poison Information Centre, Hospital for Sick Children

Research Focus:

  • Drug safety
  • Epidemiology of adverse drug events
  • Poisoning
  • Suicide

Research Summary:

Well-intended prescribing by physicians can often have unintended consequences for patients. This is sometimes because the patients in real-world clinical practice are less healthy (or less closely monitored) than those enrolled in the premarketing studies used to characterize drug safety and effectiveness. However, some drug-related side effects are sufficiently uncommon that they only become apparent after a drug has enjoyed widespread use by large numbers of patients.

Dr. Juurlink’s research explores the epidemiology of adverse drug events using anonymized population-based health care data to explore the complex interrelationships between drug therapy and harm. One of his primary interests is the clinical consequences of drug-drug interactions, which typify avoidable drug-related injury. As a medical toxicologist, he also studies the epidemiology of deliberate self-harm, including drug overdose and suicide.

Selected Publications:

See current publications list at PubMed

Related News and Stories:

Related Links: